Impact and cost-effectiveness of hepatitis B virus prophylaxis in pregnancy: a dynamic simulation modelling study

Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial

(2022) Olivier Segeral et al.   LANCET INFECTIOUS DISEASES

Diagnostic performance evaluation of hepatitis B e antigen rapid diagnostic tests in Malawi

(2021) Alexander J. Stockdale et al.   BMC INFECTIOUS DISEASES

Cost-effectiveness of adding a birth dose of hepatitis B vaccine in the Dafra district of the Hauts-Bassins Region in Burkina Faso (NéoVac Study)

(2021) Andréa Gosset et al.   VACCINE

Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility study

(2021) Peyton Thompson et al.   Lancet Global Health

The impact of the timely birth dose vaccine on the global elimination of hepatitis B

(2021) Margaret J. de Villiers et al.   Nature Communications

Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis

(2020) Anna L. McNaughton et al.   PLOS MEDICINE

Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis

(2020) Anna L Funk et al.   LANCET INFECTIOUS DISEASES

Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis

(2020) Pauline Boucheron et al.   LANCET INFECTIOUS DISEASES

Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income

(2020) David Tordrup et al.   VALUE IN HEALTH

Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa

(2019) Jolynne Mokaya et al.   BMC PUBLIC HEALTH

Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016–30

(2019) David Tordrup et al.   Lancet Global Health

Mother to child transmission of hepatitis B: What more needs to be done to eliminate it around the world?

(2019) Shevanthi Nayagam et al.   JOURNAL OF VIRAL HEPATITIS

Poor Sensitivity of Commercial Rapid Diagnostic Tests for Hepatitis B e Antigen in Senegal, West Africa

(2018) Abdoulaye Seck et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

A decision analytic model for prevention of hepatitis B virus infection in Sub-Saharan Africa using birth-dose vaccination

(2018) Sarah Anderson et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Requirements for global elimination of hepatitis B: a modelling study

(2016) Shevanthi Nayagam et al.   LANCET INFECTIOUS DISEASES

Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load

(2016) Calvin Q. Pan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cost-effectiveness analysis of an additional birth dose of Hepatitis B vaccine to prevent perinatal transmission in a medical setting in Mozambique

(2012) Corinna Klingler et al.   VACCINE